Ciglitazone is an antidiabetic drug of the thiazolidinedione structural class. Ciglitazone is a potent and selective PPARγ ligand. It binds to the PPARγ ligand-binding domain with an EC of 3.0 µM. Ciglitazone is active in vivo as an anti-hyperglycemic agent in the ob/ob mouse model.